[go: up one dir, main page]

GB201600381D0 - Virus strain - Google Patents

Virus strain

Info

Publication number
GB201600381D0
GB201600381D0 GBGB1600381.6A GB201600381A GB201600381D0 GB 201600381 D0 GB201600381 D0 GB 201600381D0 GB 201600381 A GB201600381 A GB 201600381A GB 201600381 D0 GB201600381 D0 GB 201600381D0
Authority
GB
United Kingdom
Prior art keywords
virus strain
virus
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1600381.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Replimune Ltd
Original Assignee
Replimune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replimune Ltd filed Critical Replimune Ltd
Priority to GBGB1600381.6A priority Critical patent/GB201600381D0/en
Publication of GB201600381D0 publication Critical patent/GB201600381D0/en
Priority to CN201780012759.3A priority patent/CN109153977B/en
Priority to SG11201805835WA priority patent/SG11201805835WA/en
Priority to US16/068,826 priority patent/US10570377B2/en
Priority to DK20197725.3T priority patent/DK3805376T3/en
Priority to BR112018013930-0A priority patent/BR112018013930B1/en
Priority to US16/068,830 priority patent/US10947513B2/en
Priority to PCT/GB2017/050038 priority patent/WO2017118866A1/en
Priority to ES17700384T priority patent/ES2943150T3/en
Priority to US16/068,823 priority patent/US10626377B2/en
Priority to CN201780012579.5A priority patent/CN109312309B/en
Priority to EP25185492.3A priority patent/EP4628577A2/en
Priority to PCT/GB2017/050039 priority patent/WO2017118867A1/en
Priority to JP2018555310A priority patent/JP7038065B2/en
Priority to KR1020257002985A priority patent/KR20250026348A/en
Priority to CA3010987A priority patent/CA3010987A1/en
Priority to EP17700384.5A priority patent/EP3400290B1/en
Priority to CA3011004A priority patent/CA3011004A1/en
Priority to PCT/GB2017/050037 priority patent/WO2017118865A1/en
Priority to HK18116239.7A priority patent/HK1257480B/en
Priority to AU2017205216A priority patent/AU2017205216B2/en
Priority to ES20197725T priority patent/ES3041885T3/en
Priority to JP2018555311A priority patent/JP7038664B2/en
Priority to ES17701910T priority patent/ES2831080T5/en
Priority to EP20197725.3A priority patent/EP3805376B1/en
Priority to SG10202108724YA priority patent/SG10202108724YA/en
Priority to EP20189881.4A priority patent/EP3778881A1/en
Priority to US16/068,816 priority patent/US10612005B2/en
Priority to PCT/GB2017/050036 priority patent/WO2017118864A1/en
Priority to EP23156055.8A priority patent/EP4219696A3/en
Priority to MX2018008413A priority patent/MX2018008413A/en
Priority to CA3011009A priority patent/CA3011009A1/en
Priority to DK17700385.2T priority patent/DK3400291T4/en
Priority to ES17700385T priority patent/ES2841300T5/en
Priority to JP2018555309A priority patent/JP6959258B2/en
Priority to CN201780012527.8A priority patent/CN109415703B/en
Priority to DK17701910.6T priority patent/DK3400293T4/en
Priority to EP17700385.2A priority patent/EP3400291B2/en
Priority to EP17700386.0A priority patent/EP3400292B1/en
Priority to HK18116243.1A priority patent/HK1257074B/en
Priority to HK18116229.9A priority patent/HK1257224B/en
Priority to KR1020187022799A priority patent/KR102762431B1/en
Priority to DK17700384.5T priority patent/DK3400290T5/en
Priority to EP17701910.6A priority patent/EP3400293B2/en
Priority to IL260480A priority patent/IL260480B/en
Priority to US16/740,203 priority patent/US11473063B2/en
Priority to US16/799,090 priority patent/US11427810B2/en
Priority to US17/164,635 priority patent/US12049647B2/en
Priority to IL282985A priority patent/IL282985B/en
Priority to JP2021163811A priority patent/JP7295192B2/en
Priority to JP2022034569A priority patent/JP2022078225A/en
Priority to US17/817,245 priority patent/US12458696B2/en
Priority to US17/817,618 priority patent/US12024724B2/en
Priority to AU2022279486A priority patent/AU2022279486B2/en
Priority to US18/163,837 priority patent/US12397053B2/en
Priority to JP2023094818A priority patent/JP2023113885A/en
Priority to US18/462,133 priority patent/US12465639B2/en
Priority to US18/670,296 priority patent/US20240301365A1/en
Priority to JP2024119344A priority patent/JP2024153748A/en
Priority to US19/277,600 priority patent/US20250352646A1/en
Priority to JP2025128636A priority patent/JP2025163138A/en
Ceased legal-status Critical Current

Links

GBGB1600381.6A 2016-01-08 2016-01-08 Virus strain Ceased GB201600381D0 (en)

Priority Applications (61)

Application Number Priority Date Filing Date Title
GBGB1600381.6A GB201600381D0 (en) 2016-01-08 2016-01-08 Virus strain
CN201780012759.3A CN109153977B (en) 2016-01-08 2017-01-09 Oncolytic virus strains
SG11201805835WA SG11201805835WA (en) 2016-01-08 2017-01-09 Modified oncolytic virus
US16/068,826 US10570377B2 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
DK20197725.3T DK3805376T3 (en) 2016-01-08 2017-01-09 Modified virus
BR112018013930-0A BR112018013930B1 (en) 2016-01-08 2017-01-09 ONCOLYTIC VIRUS, PHARMACEUTICAL COMPOSITION AND USES OF THE VIRUS
US16/068,830 US10947513B2 (en) 2016-01-08 2017-01-09 Engineered virus
PCT/GB2017/050038 WO2017118866A1 (en) 2016-01-08 2017-01-09 Engineered virus
ES17700384T ES2943150T3 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
US16/068,823 US10626377B2 (en) 2016-01-08 2017-01-09 Use of an oncolytic virus for the treatment of cancer
CN201780012579.5A CN109312309B (en) 2016-01-08 2017-01-09 engineered virus
EP25185492.3A EP4628577A2 (en) 2016-01-08 2017-01-09 Engineered virus
PCT/GB2017/050039 WO2017118867A1 (en) 2016-01-08 2017-01-09 Use of an oncolytic virus for the treatment of cancer
JP2018555310A JP7038065B2 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
KR1020257002985A KR20250026348A (en) 2016-01-08 2017-01-09 Modified oncolytic virus
CA3010987A CA3010987A1 (en) 2016-01-08 2017-01-09 Oncolytic herpes simplex virus type 1 strain
EP17700384.5A EP3400290B1 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
CA3011004A CA3011004A1 (en) 2016-01-08 2017-01-09 Oncolytic virus comprising a fusogenic protein-encoding gene and immune stimulatory protein-encoding gene
PCT/GB2017/050037 WO2017118865A1 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
HK18116239.7A HK1257480B (en) 2016-01-08 2017-01-09 Engineered virus
AU2017205216A AU2017205216B2 (en) 2016-01-08 2017-01-09 Modified oncolytic viurs
ES20197725T ES3041885T3 (en) 2016-01-08 2017-01-09 Engineered virus
JP2018555311A JP7038664B2 (en) 2016-01-08 2017-01-09 Manipulated oncolytic virus
ES17701910T ES2831080T5 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
EP20197725.3A EP3805376B1 (en) 2016-01-08 2017-01-09 Engineered virus
SG10202108724YA SG10202108724YA (en) 2016-01-08 2017-01-09 Modified oncolytic virus
EP20189881.4A EP3778881A1 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
US16/068,816 US10612005B2 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
PCT/GB2017/050036 WO2017118864A1 (en) 2016-01-08 2017-01-09 Modified oncolytic viurs
EP23156055.8A EP4219696A3 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
MX2018008413A MX2018008413A (en) 2016-01-08 2017-01-09 Modified oncolytic viurs.
CA3011009A CA3011009A1 (en) 2016-01-08 2017-01-09 Oncolytic virus comprising a gm-csf-encoding gene and an immune co-stimulatory pathway activating molecule-encoding gene
DK17700385.2T DK3400291T4 (en) 2016-01-08 2017-01-09 Engineered virus
ES17700385T ES2841300T5 (en) 2016-01-08 2017-01-09 Genetically modified virus
JP2018555309A JP6959258B2 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
CN201780012527.8A CN109415703B (en) 2016-01-08 2017-01-09 Modified oncolytic viruses
DK17701910.6T DK3400293T4 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
EP17700385.2A EP3400291B2 (en) 2016-01-08 2017-01-09 Engineered virus
EP17700386.0A EP3400292B1 (en) 2016-01-08 2017-01-09 Use of an oncolytic virus for the treatment of cancer
HK18116243.1A HK1257074B (en) 2016-01-08 2017-01-09 Oncolytic virus strain
HK18116229.9A HK1257224B (en) 2016-01-08 2017-01-09 Modified oncolytic virus
KR1020187022799A KR102762431B1 (en) 2016-01-08 2017-01-09 Modified anti-tumor virus
DK17700384.5T DK3400290T5 (en) 2016-01-08 2017-01-09 Oncolytic virus strain
EP17701910.6A EP3400293B2 (en) 2016-01-08 2017-01-09 Modified oncolytic virus
IL260480A IL260480B (en) 2016-01-08 2018-07-08 Modified oncolytic virus
US16/740,203 US11473063B2 (en) 2016-01-08 2020-01-10 Oncolytic virus strain
US16/799,090 US11427810B2 (en) 2016-01-08 2020-02-24 Modified oncolytic virus
US17/164,635 US12049647B2 (en) 2016-01-08 2021-02-01 Engineered virus
IL282985A IL282985B (en) 2016-01-08 2021-05-06 Oncolytic virus modifications
JP2021163811A JP7295192B2 (en) 2016-01-08 2021-10-05 modified oncolytic virus
JP2022034569A JP2022078225A (en) 2016-01-08 2022-03-07 Manipulated oncolytic virus
US17/817,245 US12458696B2 (en) 2016-01-08 2022-08-03 Modified oncolytic virus
US17/817,618 US12024724B2 (en) 2016-01-08 2022-08-04 Oncolytic virus strain
AU2022279486A AU2022279486B2 (en) 2016-01-08 2022-12-01 Modified Oncolytic Virus
US18/163,837 US12397053B2 (en) 2016-01-08 2023-02-02 Engineered virus
JP2023094818A JP2023113885A (en) 2016-01-08 2023-06-08 modified oncolytic virus
US18/462,133 US12465639B2 (en) 2016-01-08 2023-09-06 Modified oncolytic virus
US18/670,296 US20240301365A1 (en) 2016-01-08 2024-05-21 Oncolytic virus strain
JP2024119344A JP2024153748A (en) 2016-01-08 2024-07-25 Engineered oncolytic viruses
US19/277,600 US20250352646A1 (en) 2016-01-08 2025-07-23 Engineered virus
JP2025128636A JP2025163138A (en) 2016-01-08 2025-07-31 Modified oncolytic viruses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1600381.6A GB201600381D0 (en) 2016-01-08 2016-01-08 Virus strain

Publications (1)

Publication Number Publication Date
GB201600381D0 true GB201600381D0 (en) 2016-02-24

Family

ID=55445758

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1600381.6A Ceased GB201600381D0 (en) 2016-01-08 2016-01-08 Virus strain

Country Status (1)

Country Link
GB (1) GB201600381D0 (en)

Similar Documents

Publication Publication Date Title
IL267949A (en) Altered virus
GB201410971D0 (en) Vaccine
GB201405834D0 (en) Oncolytic virus
GB201406608D0 (en) Virus
GB201518684D0 (en) Vaccine
GB201405706D0 (en) Software protection
PL3185899T3 (en) Improved hvt-vectored nd-ibd vaccine
EP3388526A4 (en) DEMICROBACTERIUM STRAIN
GB201521751D0 (en) Novel uses
IL267785A (en) Virus
GB201522132D0 (en) Vaccine
IL253635A0 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
GB201419572D0 (en) Virus
GB201616904D0 (en) Vaccine
PL3256331T3 (en) Document
GB201518940D0 (en) Novel safe
HUE053284T2 (en) Vaccine
PL3558692T3 (en) Secure document
GB201603029D0 (en) Vaccine
GB201417214D0 (en) Vaccine
GB201406628D0 (en) Vaccine
GB201600381D0 (en) Virus strain
GB201716047D0 (en) Virus
GB201600380D0 (en) Modified virus
GB201700259D0 (en) Virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)